期刊文献+

β-catenin在肝癌组织中的表达及对肝癌患者预后的影响 被引量:3

β-catenin expression in hepatocellular carcinoma and its effect on prognosis
下载PDF
导出
摘要 目的:探讨β-catenin在肝细胞癌(HCC)组织中的表达及其与肝癌预后的关系。方法:用免疫组织化学方法检测83例HCC、26例癌旁组织和5例正常肝组织中β-catenin蛋白的表达情况,并对行肝癌根治性术患者进行术后随访,分析β-catenin蛋白表达与临床因素、HCC病理分化程度及患者术后生存的关系。结果:β-catenin蛋白在HCC、癌旁组织及正常肝组织中的阳性表达率分别为68.67%(57/83)、30.77%(8/26)和20%(1/5),其在HCC中的表达阳性率高于正常肝组织及癌旁组织(P<0.05);β-catenin阳性表达率与肝癌病理分化程度呈负相关(r=-0.34,P=0.027);有效随访68例,在随访的5年内,β-catenin阳性表达组平均生存时间11.2个月,β-catenin阴性表达组平均生存时间26.6个月,Kaplan-Meier生存分析表明β-catenin阴性表达患者比阳性表达患者术后生存更长,Log-Rank检验两组预后有显著性差异(χ~2=15.138,P=0.000)。结论:β-catenin与HCC分化程度相关,β-catenin在肝癌组织中的高表达提示患者预后不良。 OBJECTIVE:To detect the expression of β-catenin and its prognostic significance in hepatocellular carcinoma.METHODS:The expression of β-catenin protein was detected by immunohistochemistry in83cases of resected HCC tissues,26cases of adjacent tissues and5cases of normal liver tissues. The integrated follow-up data were rerospectively analyzed in patients who had undergone radical hepatectomy. The relationships betweenβ-catenin and clincal variables,HCC pathological differentiation and postoperative survival were statistically analyzed.RESULTS:The positive expression rates of β-catenin in the HCC tissues,adjacent tissues and normal liver tissues were 68.67% (57/83)、30.77%(8/26) and 20%(1/5). The positive rate of β-catenin in HCC was significantly higher than that of adjacent tissues and normal liver tissues (P&lt;0.05). The positive expression rates of β-catenin was negatively correlated with pathological differentiation (r=-0.34,P=0.027). In the 83 follow-up data,68 cases were effective. In the first 5 years of follow-up data,and among patients with positive expression of β-catenin,the mean survival time was 11.2 months. Among patients with negative expression of β-catenin,the mean survival time was 26.6 months. Kaplan-Meier survival analysis revealed that patients with negative expression of β-catenin had longer survival time and their prognosis was 2significantly different based on Log-rank test(χ2=15.138,P=0.000).CONCLUSION:Expression of β-catenin was correlated with pathological differentiation in HCC and its high expression predicted poor prognosis.
出处 《癌变.畸变.突变》 CAS CSCD 2017年第4期300-303,共4页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 广东省高水平大学重点学科建设"感染性疾病研究与防治"项目子项目(2016011)
关键词 肝细胞癌 Β-CATENIN 免疫组化 预后 hepatocellular carcinoma β-catenin immunohistochemistry prognosis
  • 相关文献

参考文献3

二级参考文献51

  • 1匡志鹏,谢裕安,杨帆,梁安民,罗小玲,吴继宁.C57BL/6J小鼠肝癌动物模型的建立[J].中国普通外科杂志,2007,16(7):657-660. 被引量:37
  • 2Calvisi DF, Factor VM, Ladu S, Conner EA, Thorgeirsson SS.Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice. Gastroenterology 2004; 126:1374-1386.
  • 3Ozturk M. Genetic aspects of hepatocellular carcinogenesis.Semin Liver Dis 1999; 19:235-242.
  • 4Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T,Petmecky K, Eilers R, Dienes HP, Schirmacher P. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53,but not with expression of conventional WNT-1 target genes.J Pathol 2003; 201:250-259.
  • 5Torbenson M, Kannangai R, Abraham S, Sahin F, Choti M,Wang J. Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellularcar cinoma. Am J Clin Pathol 2004; 122:377-382.
  • 6Wel Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P,Buendia MA. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology 2002; 36:692-701.
  • 7Cui J, Zhou X, Liu Y, Tang Z, Romeih M. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes. J Gastroenterol Hepatol 2003; 18:280-287.
  • 8Suzuki T, Yano H, Nakashima Y, Nakashima O, Kojiro M. β-Catenin expression in hepatocellular carcinoma: A possible participation of β-catenin in the dedifferentiation process. J Gastroenterol Hepatol 2002; 17:994-1000.
  • 9Harada N, Oshima H, Katoh M, Tamai Y, Oshima M, Taketo MM. Hepatocarcinogenesis in mice with beta-catenin and Haras gene mutations. Cancer Res 2004; 64:48-54.
  • 10Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M,Shimazaki J, Yoshimi F, Fukao K. Expression and prognostic roles of β-Catenin in hepatocellular carcinoma. Clin Cancer Res 2002; 8:450-456.

共引文献19

同被引文献17

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部